Plus   Neg

Gilead Sciences Inc. Q4 Profit Retreats

Gilead Sciences Inc. (GILD) released earnings for fourth quarter that retreated compared to the same period last year.

The company said its bottom line totaled $2.34 billion, or $1.78 per share. This was lower than $3.59 billion, or $2.70 per share, in last year's fourth quarter.

Analysts had expected the company to earn $1.67 per share, according figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company said revenue for the quarter fell 18.7% to $5.95 billion. This was down from $7.32 billion last year.

Gilead Sciences Inc. earnings at a glance:

-Earnings (Q4): $2.34 Bln. vs. $3.59 Bln. last year.
-Earnings Decline (Y-o-Y): -34.8%
-EPS (Q4): $1.78 vs. $2.70 last year.
-EPS Decline (Y-o-Y): -34.1%
-Analysts Estimate: $1.67
-Revenue (Q4): $5.95 Bln vs. $7.32 Bln last year.
-Revenue Change (Y-o-Y): -18.7%

Full year EPS guidance: $1.41 - $1.51
Full year revenue guidance: $20 - $21 Bln

For comments and feedback contact: editorial@rttnews.com

Follow RTT